Shenandoah

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

InduPro

This biotechnology company develops proximity-based protein therapeutics for patients with cancer and autoimmune diseases.

Enodia

This company develops small-molecule therapies that degrade disease-causing proteins at the point of synthesis for patients with cancer and inflammatory diseases.

KyDo

This biotechnology company develops small molecule inhibitors for the treatment of cancer variants in oncology patients.

ProteoValent Therapeutics

This company develops targeted protein degrader therapies for cancer and haematology patients.

Sensei Bio

This biotechnology company develops multi-node pathway inhibitors and immunotherapy treatments for cancer patients.

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.

Ligature Therapeutics

This biotech company develops protein degrader therapeutics using a fragment-based discovery platform to treat intractable diseases for patients with cancer.